Literature DB >> 27120495

In Reply.

Sibylle Koletzko.   

Abstract

Year:  2016        PMID： 27120495      PMCID： PMC4857556          DOI： 10.3238/arztebl.2016.0222

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

1.  The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.

Authors:  Kirsi Mustalahti; Carlo Catassi; Antti Reunanen; Elisabetta Fabiani; Margit Heier; Stan McMillan; Liam Murray; Marie-Helene Metzger; Maurizio Gasparin; Enzo Bravi; Markku Mäki
Journal:  Ann Med       Date:  2010-12       Impact factor: 4.709

2.  Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening.

Authors:  Charlotta Webb; Fredrik Norström; Anna Myléus; Anneli Ivarsson; Britta Halvarsson; Lotta Högberg; Carina Lagerqvist; Anna Rosén; Olof Sandström; Lars Stenhammar; Annelie Carlsson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-06       Impact factor: 2.839

3.  Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.

Authors:  Dominica Gidrewicz; Kathryn Potter; Cynthia L Trevenen; Martha Lyon; J Decker Butzner
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

4.  The prevalence of celiac disease in children and adolescents in Germany.

Authors:  Martin W Laass; Roma Schmitz; Holm H Uhlig; Klaus-Peter Zimmer; Michael Thamm; Sibylle Koletzko
Journal:  Dtsch Arztebl Int       Date:  2015-08-17       Impact factor: 5.594

5.  Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in sequential testing.

Authors:  Olof Sandström; Anna Rosén; Carina Lagerqvist; Annelie Carlsson; Olle Hernell; Lotta Högberg; Anneli Ivarsson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-10       Impact factor: 2.839
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.